The inducibility of pancreatic islet cell tumors by administration of 4-hydroxyaminoquinolin e 1-oxide (4HAQO) was investigated in male 6-weekold Sprague-Dawley rats. Rats were given 4HAQO intravenously at a weekly dose of 5 mg/kg 4 times (group 1) or a single dose of 10 mg/kg (group 2). Control rats received the vehicle alone (group 3). Fifty-six weeks after the rst 4HAQO administration, all surviving animals were killed and the pancreas was examined histopathologically, immunohistochemicall y and ultrastructurally. The incidences and multiplicities of islet cell tumors in groups 1, 2, and 3 were 52.3% ( p < 0.05 vs group 2, p < 0.01 vs group 3), 19.2% and 0%, and 0.70/animal ( p < 0.05 vs group 2, p < 0.01 vs group 3), 0.23 and 0, respectively. Islet cell carcinomas were induced only in group 1, accounting for 6/44 (26%) tumors. Islet cell hyperplasias were found in 61.4% ( p < 0.05 vs group 3), 42.3% and 10.0% of groups 1, 2, and 3, with multiplicities of 0.95 ( p < 0.05 vs groups 2 and 3), 0.54 and 0.20, respectivel y. As compared with normal islets from control subjects, islet cell tumors showed an increase in the number of insulin positive cells associated with cytological features indicative of enhanced insulin synthesis and secretion, and a decrease in the number of glucagon positive cells without ultrastructural signs of modi ed secretory activity. Thus our results indicate that repeated intravenous administration of 4HAQO to rats is useful for the induction of islet cell tumors at high incidence.
INTRODUCTION
4-Hydroxyaminoquinolin e 1-oxide (4HAQO), a reactive oxidative metabolite of 4-nitroquinoline 1-oxide (4NQO), is known as a potent carcinogen with clear organotropism and species speci city (9, 14, 19, 23, 28) . It has been well-documented that a single intravenous administration of 4HAQO preferentially induces pancreatic acinar cell tumors in rats (7, 8, 16, 27) , and a subcutaneous injection results in the development of pulmonary tumors in mice (18) . Extensive studies on the positive interaction of 4HAQO or 4NQO with DNA have been carried out using bacteria, transplantable ascites tumor cells, cultured mammalian cells, and DNA itself (10, 21, 30) . Furthermore, covalent binding of 4HAQO to DNA to form quinoline adducts has been indicated to be essentially signi cant for the initiation of rat pancreatic acinar cell carcinogenesis by this agent (4, 22) . In our previous study (11) , DNA adduct formation evaluated by an immunohistochemical method using an antibody directed against 4HAQO-DNA adducts was consistently demonstrated in the target organs of rats given a single injection of 4HAQO. The staining pattern of 4HAQO-DNA adducts differed according to the anatomic location or cell type. For example, nuclei of the pancreatic acinar cells were clearly positive, and those of the islet cells and adrenal cortical cells were relatively weak stained nuclei. Recently, we found adrenal peliosis, mimicking the age-associated degeneration change, located in the zona faciculata and zona reticularis induced at 20 weeks after 4HAQO injection in rats (12) .
Characteristics of human pancreatic endocrine tumors have been well-described (3, 15) . Islet cell adenomas in rats are mostly of B-cell origin and develop in some experimental models with alloxan or streptozotocin treatment (33, 35) . Other chemicals that have been reported to induce islet cell neoplasias are heliotrine (26) and azinophosmethyl (17) . These chemicals induce mostly adenomas, with a small proportion of carcinomas. It is known that a single intravenous injection of 4HAQO can cause not only pancreatic exocrine tumors but also endocrine lesions after partial pancreatectomy and splenectomy (13) . In the present study, the capacity of 4HAQO to induce islet cell tumors was examined in intact rats. In addition, lesions induced by repeated or a single intravenous injection of 4HAQO were characterized for insulin, glucagon, and somatostatin immunoreactivity, as well as ultrastructural features.
MATERIALS AND METHODS
Male 6-week-old Sprague-Dawley rats (Sankyo Laboratory, Tokyo, Japan), initially weighing approximately 160 g, were used in the experiment. They were housed, 4 per wire cage, in an air-conditioned room maintained at 24 1 C and 55 5% relative humidity under a daily cycle of alternating 12 hours periods of light and darkness. The animals were given a commercial standard diet (CRF-1: Charles River, Tokyo) and tap water ad libitum.
After a 1-week acclimatization period, 50 rats were given 4HAQO (Iwai Chemicals, Tokyo) dissolved in 0.005 M hydrochloric acid into the saphenous vein at a weekly dose of 5 mg/kg for 4 weeks (group 1) and 30 rats were given 320 0192-6233/01$3.00 $0.00 a single dose of 10 mg/kg (group 2). Ten control rats received 4 weekly intravenous injections of acidic aqueous solution alone (group 3). Fifty-six weeks after the rst 4HAQO administration, all surviving animals were sacri ced under ether anaesthesia, and the pancreatic tissues were examined histopathologically.
Tissue specimens were xed in 10% phosphate-buffered formaldehyde solution for 24 hours at room temperature, embedded in paraf n, sectioned at 3 to 4 l m, and routinely stained with hematoxylin and eosin (H&E). Serial sections were prepared for immunohistochemical investigation in rats killed at termination. For all islet cell tumors, expression and localization of insulin, glucagon, and somatostatin were examined with polyclonal antibodies (Dako Japan, Kyoto, Japan; diluted 1:400) against each antigen using a labeled streptavidin biotin method.
For characterization of islet cell tumors, small tissue specimens from 10 macroscopic tumors were xed in 0.1 M phosphate buffered (pH7.4) glutaraldehyde for 2 hours, at 4 C and post xed in 0.1 M phosphate buffered 1% OsO 4 for 1 hour, at 4 C. They were dehydrated in graded ethyl alcohol, passed through propylene oxide, and embedded in Epon 812. Thereafter, ultrathin sections were double-contrasted with uranyl acetate and lead citrate, and observed under a JEM-100CXS electron microscope (JEOL, Tokyo).
RESULTS
In groups 1 and 2, 22/50 (44%) and 16/30 (53.3%) rats respectively died of possible toxic effects within 55 weeks of the administration of 4HAQO. There were no animals that died immediately after the injection of 4HAQO, whereas about half animals, 16 and 12 rats of groups 1 and 2, respectively, during the experimental week 55 died of malignant tumors such as pancreatic, intestinal, lung, and adrenal cancers, and leukemia. Respectively, 6 and 4 rats from groups 1 and 2 that were found dead with advanced autolysis in the middle of experiment were excluded from the effective numbers of animals.
Fifty-six weeks after the rst 4HAQO administration, all surviving animals were sacri ced. Histopathological ndings for lesions of pancreatic islets are summarized in Table 1 . The incidences of islet cell tumors were 23/44 (52.3%), 5/26 (19.2%), and 0/10 (0%) respectively in groups 1, 2, and 3, being signi cantly higher in group 1 than in groups 2 and 3. Islet cell carcinomas were induced in 6 rats of group 1 and 1 rat of group 2, accounting for 6/23 (26%) and 1/5 (20%) tumors, respectively. Similarly, the incidences of islet cell hyperplasias were respectively 61.4%, 42.3%, and 10.0% in groups 1, 2, and 3, and signi cantly higher in group 1 than in group 3. The multiplicities of islet cell tumors were, respectively, 0.70/animal, 0.23, and 0 and those of islet cell hyperplasias were, respectively, 0.95, 0.54, and 0.20, in groups 1, 2, and 3, again signi cantly greater in group 1 than in group 3 ( Table 2) . Hyperplastic islets were interpreted to be lesions with diameters up to 500 l m or more (24) . Generally, hyperplastic islets retained normal oval-to-round outlines or became lobulated and irregular ( Figure 2 ). The islet cell tumors ranged in size from 2 to 9 mm in diameter as measured on stained sections. Islet cell adenomas were discrete and well-circumscribed, and compressed the surrounding acinar tissues (Figure 3 ). The growth pattern of islet cell adenomas varied, consisting of nests or solid clusters, but neither significant pleomorphism or mitotic activity were exhibited. Islet cell carcinomas were well-differentiated showing trabecular and lobular patterns with local or capsular invasion (Figure 4 ). The incidences of pancreatic acinar cell tumors were 81.8%, 73.1%, and 0% in groups 1, 2, and 3, respectively. Immunohistochemistry with polyclonal anti-insulin, antiglucagon, and antisomatostatin antibodies revealed islet cells stained very strongly positive for insulin, predominantly in control rats ( Figures 1A and B ). In contrast, glucagon and somatostatin labeled cells, with weak to strong reactivity, were scattered at the periphery of islets ( Figures 1C and  D) . In hyperplastic islet cells, insulin-immunoreactive cells were again strongly positive in the central areas ( Figure 2B ), yet glucagon-immunoreactive cells were frequently limited to peripheral incomplete rings ( Figure 2C ). Somatostatinpositive cells tended to be fusiform and aligned in the periphery ( Figure 2D ). The immunohistochemical ndings for insulin, glucagon, and somatostatin in islet cell tumors are summarized in Table 3 . All 16 tumors were stained strongly for insulin ( Figures 3B and 4B ). Eleven of 13 adenomas contained a few scattered positive cells and/or locally aggregated positive cells for glucagon and somatostatin, extending into the centers of the lesions (Figures 3C and 3D ). All 3 carcinomas were negative for glucagon ( Figure 4C ), and contained Adenoma  13  0  13  2  7  4  2  8  3  Carcinoma  3  0  3  3  0  0  0 individual or small clumps of cells, which stained for somatostatin ( Figure 4D) .
Ultrastructurally, the tumor cells in either adenomas or carcinomas were polyhedral with variable amounts of cytoplasm. Islet cell adenomas had abundant areas containing immature B-cell secretory granules of variable electron density and large-sized mitochondria ( Figures 5A and B) . Carcinomas were characterized by greater amounts of polyribosomes, well-developed Golgi apparatus and endoplasmic reticulum, and scant granules ( Figure 6 ). Occasionally, agranular cells were also observed in tumors.
DISCUSSION
In a previous study, a single intravenous administration of 4HAQO to rats at a dose of 7 mg/kg body weight was found to induce B-cell islet tumors in 6/15 (40%) animals after 52 weeks, when the carcinogen was administered 3 days after partial pancreatectomy and splenectomy (13) . The present study demonstrated that 4HAQO, with repeated administration at a dose of 5 mg/kg body weight, has marked tumorigenic action on the SD rat endocrine pancreas, while a single administration at a dose of 10 mg/kg body weight has much weaker effects, the ratio for lesions being 2.7:1. In contrast, pancreatic acinar cell tumors were induced at incidences of 81.8% and 73.1%, respectively. These results suggest that repeated intravenous administration of 4HAQO is appropriate to produce pancreatic islet cell tumors.
Spontaneous tumors of the pancreas, especially of islet cell origin, are rare in rats and other laboratory animals (25) . Dillberger (5) reported that islet cell neoplasia did not occur in rats before 17 months. Although the 4HAQO-treated rats of groups 1 and 2 showed a high mortality in this experiment model, the survival rate was higher in group 1 than in group 2. Further improvement in the 4HAQO treatment regimen could appreciably increase the survival rate. For example, more administrations at lower doses or longer intermittent intervals might be effective.
Continued synthesis of insulin in neoplastic islet cells was revealed by the present immunohistochemical and ultrastructural ndings. The immunohistochemical identi cation of insulin in 100% of the 4HAQO-induced islet cell tumors supports the conclusion that these neoplasms are principally of B-cell origin, although glucagon-or somatostatin-containing cells were also present, at least in adenomas, if only in small numbers. The immunocytochemical ndings for islet cell tumors induced in Wistar rats by administration of streptozotocin or nicotinamide (20, 34) resemble the pattern observed in the present study. The 3 carcinomas induced by repeated administration of 4HAQO in rats sacri ced at the termination showed trabecular and lobular growth patterns with strongly positive immunohistochemical staining for insulin. Although the lack of glucagon immunoreactivity suggested a homogeneous population of B-cells, ultrastructural studies con rmed that they were morphologically heterogeneous, as reported in humans (29) . Ultrastructurally, all examined tumor cells appeared granulated even though the number and electron density of secretory granules varied from case to case, probably indicating immaturity in adenomas. Golgi apparatus and endoplasmic reticulum were also occasionally observed in agranular or poorly granular cells suggesting active secretion in carcinomas. Similarly, atypical secretory granules have infrequently been observed in human islet cell tumors (1-3, 6, 14, 30-32) . These cells often showed signs of functional activity with well developed Glgi apparatus and endoplasmic reticulum (3, 6) . Very rarely, granules resembling those of A or D cells have been detected in a few cells of certain human B cell tumors, but cells with ultrastructural characteristics of A or D cells were not observed in any of rat pancreatic islet cell tumors examined in the present study.
In 4HAQO-induced pancreatic acinar cell tumorigenesis, it is assumed that covalent binding of the ultimate carcinogen with DNA is of prime importance for tumor initiation (16) . Likewise, relatively high incidences of pancreatic islet cell tumors in rats receiving 4HAQO may be attributed to accumulation of 4HAQO-DNA adducts, which were detected in both pancreatic exocrine and endocrine tissues by immunohistochemistry using anti-4HAQO-DNA antibody in our earlier study (11) . Pancreatic islet cell carcinogenesis may be enhanced by regenerative processes induced by repeated administration of toxic doses of 4HAQO. Further experiments to elucidate the detailed histogenesis of pancreatic islet cell tumors are now in progress in this laboratory.
In conclusion, the present study showed that repeated administrations of 4HAQO induce islet cell tumors of B-cell origin in rats at high incidence. This animal model could be a useful tool for the analysis of islet cell tumorigenesis. Its usefulness as a model for human pancreatic cancer is somewhat limited because 90% of pancreatic cancers seen in the clinic are found in the exocrine pancreas and only 10% occur in the endocrine portion.
